OR WAIT null SECS
- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Contacts
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2024 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
The Future Role of 3D Printing in Personalized Medicines
On the last day of CPhI Worldwide (Thursday Nov. 7, 2019), several experts will examine the potential role of three-dimensional printing within medicines, particularly in light of the shift in the industry from volume to value.
On the last day of CPhI Worldwide (Thursday Nov. 7, 2019), several experts will examine the potential role of three-dimensional printing within medicines, particularly in light of the shift in the industry from volume to value.
As smaller patient populations are being addressed by companies and more personalized and complex therapeutic solutions and being favored, exploration of alternative technologies, such as 3D printing, are being explored. In the panel discussion, several experts will look at the current capabilities and future potential of 3D printing technologies, the potential impact the technology may have on personalized medicines, an overview of technologies currently available, and they will present a case study on the subject matter.
Included on the panel will be Dr. Alvaro Goyanes (FabRx), Beau Jackson (3D Printing Industry), Craig Johnston (EMAC Future Manufacturing Research Hub), Ian Rees (Medicines and Healthcare products Regulatory Agency), and Jae Yoo (Aprecia Pharmaceuticals).
Made to Order: 3D Printing for Personalized Medicines
Thursday Nov. 7, 2019
10:30–11:40
ICSE Theatre (120G43)
